Related Experiment Video
Updated: Jul 16, 2026
03:40
Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
Published on: December 8, 2023
Hematopoietic cell transplantation: progress and obstacles.
1University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE 68198-7680, USA. mdevetten@unmc.edu
Summary
Hematopoietic cell transplantation has advanced with new stem cell sources and agents, significantly reducing complications. Reduced intensity regimens now allow elderly patients to undergo transplantation, though long-term issues require attention.
Area of Science:
- Hematology
- Transplantation Immunology
- Oncology
Background:
- Hematopoietic cell transplantation (HCT) has undergone significant evolution over the past decade.
- Introduction of novel stem cell sources and mobilizing agents has expanded clinical applications.
- Advances in understanding immune-mediated effects have transformed transplant protocols.
Purpose of the Study:
- To review the recent advancements in hematopoietic cell transplantation.
- To highlight the impact of new technologies and reduced intensity regimens.
- To address emerging long-term complications in HCT.
Main Methods:
- Review of recent clinical practice changes in hematopoietic cell transplantation.
- Analysis of outcomes related to new stem cell sources and mobilizing agents.
- Evaluation of reduced intensity and non-myeloablative conditioning regimens.
Main Results:
- Dramatic decrease in life-threatening complications following autologous stem cell transplants.
- Development of reduced intensity and non-myeloablative regimens enabling elderly patient transplantation.
- Emergence of long-term complications as a significant future concern.
Conclusions:
- Hematopoietic cell transplantation has become safer and more accessible, particularly for elderly patients.
- Ongoing research is crucial to manage and mitigate long-term complications.
- Future focus will be on addressing the long-term sequelae of successful transplantation.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...